News
Opioid prescribing laws having an impact
August 11, 2021
The number of days an opioid was prescribed for each Medicare beneficiary decreased by 11.6 days in 2018 in states that imposed duration limits.
News
DOACs best aspirin after ventricular ablation: STROKE-VT
August 2, 2021
Cerebrovascular protection was far better on DOACs after catheter ablation for VT or extrasystoles in the trial and may yet be further improved.
![1]()
News
Direct oral anticoagulants: Competition brought no cost relief
July 27, 2021
Medicare Part D spending since 2011 has far outpaced growth in the use of oral anticoagulants.
![1]()
News
Statins again linked to lower COVID-19 mortality
July 21, 2021
Patients hospitalized for COVID-19 who had been taking statins had a substantially lower risk of death and severe outcomes than those who weren’t in a large observational study.
![1]()
News
Treatment of opioid use disorder with buprenorphine and methadone effective but underutilized
July 19, 2021
In clinical practice, what is the effectiveness of different treatment pathways for opioid use disorder?
News
Legalization of cannabis tied to drop in opioid-related ED visits
July 16, 2021
Nearly half of the U.S. population lives in a state that allows recreational cannabis use.
News
Record number of U.S. drug overdoses in 2020
July 14, 2021
The spikes are largely attributed to the rise in the use of fentanyl and other synthetic opioids.
![1]()
News
Default EMR settings can influence opioid prescribing
July 6, 2021
Does changing the EMR default setting for opioid prescriptions change the quantity of opioids prescribed at discharge from the emergency department?
News
Profound brain changes found in patients who died of COVID-19
June 25, 2021
“The signature the virus leaves in the brain speaks of strong inflammation and disrupted brain circuits.”
News
Reversal agents curb DOAC-related bleeding but deaths still high
June 17, 2021
The meta-analysis of more than 4,000 patients also showed thrombotic events were more frequent with andexanet than with 4PCC or idarucizumab.
